Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New rules for anticancer vaccines

22.09.2014

Scientists have found a way to find the proverbial needle in the cancer antigen haystack, according to a report published in The Journal of Experimental Medicine.

As cancer cells divide, they accumulate random mistakes (mutations). This process creates new versions of proteins, some of which are recognized as foreign invaders by immune cells called T cells, prompting the cells to attack and eliminate the cancer cells.


This simulation shows structural differences between mutant (yellow) and normal (orange) immune targets called neoepitopes. Researchers reveal how evaluating these distinctions can help pinpoint neoepitopes that elicit anticancer immune responses.

Credit: Duan et al., 2014

With our current ability to identify all of the mutations in a patient's cancer and to understand which protein sequences can be recognized by T cells, scientists can now predict which mutations will result in new T cell targets (called "neoepitopes"). Some of these neoepitopes can then be used as vaccines to elicit a protective T cell response that destroys the cancer.

But here's the catch. These prediction tools generate hundreds of possible neoepitopes, of which only a handful can actually elicit T cells capable of attacking the tumor. And so far, there has been no reliable common denominator to help pinpoint this useful handful.

Previous attempts to predict cancer neoepitopes have relied on how strongly the mutated protein is recognized by the immune system. But scientists at the University of Connecticut now show that the strength of this interaction is a poor predictor. A better (albeit still imperfect) measure turns out to be how different the mutation looks to the T cell when compared to its normal counterpart—the more distinct, the better. These results have the potential to completely change current approaches to generating anticancer vaccines.

###

Duan, F., et al. 2014. J. Exp. Med. doi:10.1084/jem.20141308

About The Journal of Experimental Medicine

The Journal of Experimental Medicine (JEM) is published by The Rockefeller University Press. All editorial decisions on manuscripts submitted are made by active scientists in conjunction with our in-house scientific editors. JEM content is posted to PubMed Central, where it is available to the public for free six months after publication. Authors retain copyright of their published works and third parties may reuse the content for non-commercial purposes under a creative commons license. For more information, please visit http://www.jem.org .

Research reported in this press release was supported by Cancer Research Institute NY, Northeastern Utilities, Connecticut Institute for Clinical and Translational Science, SPARK, the National Science Foundation, the National Institutes of Health, Life Technologies, and the USDA National Institute of Food and Agriculture.

Rita Sullivan King | Eurek Alert!

More articles from Health and Medicine:

nachricht Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences

nachricht What does congenital Zika syndrome look like?
24.03.2017 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>